Insider · CIK 0001759453
InvaGen Pharmaceuticals, Inc.
Files at ATXI (AVENUE THERAPEUTICS, INC.). First filing Oct 13, 2022, latest Oct 13, 2022.
In brief
InvaGen Pharmaceuticals, Inc. files SEC Form 4 as 10% owner at ATXI (AVENUE THERAPEUTICS, INC.). Since Oct 13, 2022, InvaGen Pharmaceuticals, Inc. has reported 0 open-market buys worth $0 and 1 open-market sell worth $3.0M, the latest filed on Oct 13, 2022.
A track record needs three past buys with six months of prices behind them; InvaGen Pharmaceuticals, Inc. has 0, so none is measured yet.
The newest scored trade: sold $3.0M of ATXI on Oct 11, 2022, filed Oct 13, 2022, scored 57 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ATXI: AVENUE THERAPEUTICS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 57Moderate | ATXIsell AVENUE THERAPEUTICS, INC. | $3.0M 388,888 shares | -100% | +10% from low-89% from high |
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 11, 2022 | ATXI AVENUE THERAPEUTICS, INC. | SOpen-market sale Common Stock, par value $0.0001 per share | -388,888 | $7.71 | $3.0M | 0 | Oct 13, 2022 |
Questions about InvaGen Pharmaceuticals, Inc.
Answered from the filings on this page, as of the latest one.
Is InvaGen Pharmaceuticals, Inc. buying or selling?
Not in the last 12 months. InvaGen Pharmaceuticals, Inc.'s latest open-market trade on SEC Form 4 was sold $3.0M of ATXI on Oct 11, 2022.
How did InvaGen Pharmaceuticals, Inc.'s past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and InvaGen Pharmaceuticals, Inc. has 0.
Where does InvaGen Pharmaceuticals, Inc. file Form 4?
InvaGen Pharmaceuticals, Inc. has filed Form 4 at ATXI (AVENUE THERAPEUTICS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.